The Pressure To Move Fast Every team building a new cell therapy hits the same wall. Investors want speed. Patients need speed. But biology does not care about either. I have run programs where the fastest path on paper turned into the slowest path in

Throughout my career in immunology and biotechnology, I have been fascinated by the possibility of moving medicine beyond simply managing disease and toward repairing or replacing what has been damaged. That is one of the reasons I find regenerative medicine so compelling. It represents a

Throughout my career, I have had the opportunity to work in both academic science and biotechnology, and that experience has shaped how I think about innovation. Academia is an extraordinary environment for asking fundamental questions and expanding our understanding of biology. Biotechnology provides another perspective.

Throughout my career in immunology, academia, and biotechnology, I have been fortunate to experience many different stages of the journey from scientific discovery to therapeutic development. I have seen the excitement of uncovering new biological insights, the challenges of building companies around promising technologies, and

The field of biotechnology is experiencing one of the most exciting periods in its history. Advances in cell therapy, gene editing, immunotherapy, and regenerative medicine are creating opportunities to address diseases that were once considered untreatable. As someone who has spent much of my career

Why Manufacturing Matters More Than Ever When people think about cell therapy, they often focus on the science. They think about engineered cells, immune responses, and the promise of treating diseases that were once considered untreatable. But in my experience, one of the most critical